We are live on ! Find out more
WCM

Washington Capital Management Portfolio holdings

AUM $152M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.9%
5 Year Est. Return
+81.36%
10 Year Est. Return
+354.14%
AUM
$88M
AUM Growth
-$326K
Cap. Flow
-$2.82M
Cap. Flow %
-3.21%
Top 10 Hldgs %
34.04%
Holding
108
New
11
Increased
23
Reduced
14
Closed
15

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$2.33M
2
VTRS icon
Viatris
VTRS
+$2.02M
3
GG
Goldcorp Inc
GG
+$1.45M
4
SLB icon
SLB Ltd
SLB
+$1.28M
5
ORCL icon
Oracle
ORCL
+$1.18M

Sector Composition

Rank Sector Weight
1 Healthcare 13%
2 Financials 12.45%
3 Industrials 11.92%
4 Communication Services 9.61%
5 Technology 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEE
101
DELISTED
Sealed Air
SEE
-11,300
Closed -$520K
SLB icon
102
SLB Ltd
SLB
$73.6B
-29,320
Closed -$1.28M
VRSK icon
103
Verisk Analytics
VRSK
$25.4B
-4,000
Closed -$532K
VTRS icon
104
Viatris
VTRS
$20.4B
-71,440
Closed -$2.02M
WCC
105
WESCO International
WCC
$16.7B
-7,600
Closed -$403K
CLDR
106
DELISTED
Cloudera, Inc.
CLDR
-38,900
Closed -$426K
ULTI
107
DELISTED
Ultimate Software Group Inc
ULTI
-1,700
Closed -$561K
GG
108
DELISTED
Goldcorp Inc
GG
-126,460
Closed -$1.45M

Similar funds

Washington Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Washington Capital Management held 108 positions worth $88M, down 0.37% from $88.3M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Washington Capital Management withdrew a net $2.82M in Q2 2019, closing 15 positions and reducing 14 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

Against the trend, Washington Capital Management opened a new position in Newmont worth $2.12M.

  • Washington Capital Management's largest Q2 2019 buy was Newmont: 55,024 shares worth $2.12M.
  • Washington Capital Management added most to Vanguard Morningstar Total Stock Market ETF in Q2 2019, an estimated $2.7M increase.
  • Washington Capital Management's biggest Q2 2019 reduction was Synopsys, cutting an estimated $241K.
  • Washington Capital Management fully exited iShares Biotechnology ETF in Q2 2019, selling an estimated $2.33M.
  • Washington Capital Management's ten largest holdings make up 34% of its $88M portfolio in Q2 2019.
  • Washington Capital Management opened 11 new positions and closed 15 in Q2 2019.
  • Washington Capital Management's portfolio value fell 0.37% quarter-over-quarter to $88M.

Based on Washington Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.